WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2013

Feb 21, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-02-19

Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-19	Common Stock	A	20784.0000	$59.1100	Acquired	503012.3871	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-19	Stock Option (Right to Buy)	$59.1100	A	87796.0000	Acquired	2023-02-19	Common Stock (87796.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1332.0944	Indirect
Common Stock	20421.2291	Indirect

Footnotes

F1: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2010 that have vested for performance period 9.